BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 2208153)

  • 1. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
    Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
    Zhou JY; Norman AW; Lübbert M; Collins ED; Uskokovic MR; Koeffler HP
    Blood; 1989 Jul; 74(1):82-93. PubMed ID: 2665845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.
    Zhou JY; Norman AW; Chen DL; Sun GW; Uskokovic M; Koeffler HP
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3929-32. PubMed ID: 2339131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP
    Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
    Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F; Mayer E; Norman AW
    Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
    Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
    J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs.
    Bishop JE; Collins ED; Okamura WH; Norman AW
    J Bone Miner Res; 1994 Aug; 9(8):1277-88. PubMed ID: 7976510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
    Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
    Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxyvitamin D3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia).
    Zhou LX; Nemere I; Norman AW
    J Bone Miner Res; 1992 Apr; 7(4):457-63. PubMed ID: 1319106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
    Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
    Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
    Sokoloski JA; Shyam K; Sartorelli AC
    Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro effect of 1,25-dihydroxyvitamin D3 and 1,25-dihydroxy-16-ene-23-yne-vitamin D3 on the proliferation and differentiation of avian chondrocytes: their role in tibial dyschondroplasia.
    Farquharson C; Rennie JS; Loveridge N; Whitehead CC
    J Endocrinol; 1996 Mar; 148(3):465-74. PubMed ID: 8778225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.